Acido pamidronico [INN-Spanish] en es it fr

Acido pamidronico [INN-Spanish] Brand names, Acido pamidronico [INN-Spanish] Analogs

Acido pamidronico [INN-Spanish] Brand Names Mixture

  • No information avaliable

Acido pamidronico [INN-Spanish] Chemical_Formula

C3H11NO7P2

Acido pamidronico [INN-Spanish] RX_link

http://www.rxlist.com/cgi/generic/aredia.htm

Acido pamidronico [INN-Spanish] fda sheet

Acido_pamidronico_[INN-Spanish] FDA

Acido pamidronico [INN-Spanish] msds (material safety sheet)

Acido_pamidronico_[INN-Spanish] MSDS

Acido pamidronico [INN-Spanish] Synthesis Reference

No information avaliable

Acido pamidronico [INN-Spanish] Molecular Weight

235.07 g/mol

Acido pamidronico [INN-Spanish] Melting Point

No information avaliable

Acido pamidronico [INN-Spanish] H2O Solubility

No information avaliable

Acido pamidronico [INN-Spanish] State

No information avaliable

Acido pamidronico [INN-Spanish] LogP

-3.048

Acido pamidronico [INN-Spanish] Dosage Forms

Liquid; Powder for solution; Solution

Acido pamidronico [INN-Spanish] Indication

For the treatment of moderate or severe hypercalcemia associated with malignancy

Acido pamidronico [INN-Spanish] Pharmacology

Pamidronate is in a class of drugs called bisphosphonates. Pamidronate reduces breakdown of the bones. Pamidronate is used in the treatment of Paget's disease of bone; to reduce high levels of calcium in the blood associated with malignancy (cancer); and to reduce the breakdown of bone due to metastases of breast cancer or multiple myeloma.

Acido pamidronico [INN-Spanish] Absorption

No information avaliable

Acido pamidronico [INN-Spanish] side effects and Toxicity

Side effects include an allergic reaction, kidney problems, seizures, low levels of calcium, magnesium, or phosphorus in the blood

Acido pamidronico [INN-Spanish] Patient Information

No information avaliable

Acido pamidronico [INN-Spanish] Organisms Affected

Humans and other mammals